Sfoglia per AUTORE
GILLI F
Collezione AOU San Luigi di Orbassano

  

Items : 25

Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-? and interleukin-4 response. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2012 Oct;18(10):1484-92. doi: 10.1177/1352458512440349. Epub 2012 May 4.
2012
AOU San Luigi di Orbassano

Gilli F; Navone ND; Valentino P; Granieri L; Perga S; Malucchi S; Bertolotto A;

2012
AOU San Luigi di Orbassano

Barrizzone N; Leone MA; Esposito F; Lucenti A; Harbo HF; Goris A; Kockum I; Oturai AB; Celius EG; Mero IL; Dubois B; Olsson T; Søndergaard HB; Cusi D; Lupoli S; Guerini F; Galimberti D; Salvetti M; Liberatore G; Naldi P; Myhr K-M; Bergamaschi R; Comi G; Martinelli Boneschi F; D'Alfonso S; Marnetto F; Caldano M; Sala A; Malucchi S; et alii...

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.
2011
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.
2011
AOU San Luigi di Orbassano

Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;

Role of differential expression of interferon receptor isoforms on the response of multiple sclerosis patients to therapy with interferon beta. in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research / J Interferon Cytokine Res. 2010 Oct;30(10):733-41. doi: 10.1089/jir.2010.0098.
2010
AOU San Luigi di Orbassano

Gilli F;

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.
2010
AOU San Luigi di Orbassano

Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;

Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica. in Journal of neuroimmunology / J Neuroimmunol. 2009 Dec 10;217(1-2):74-9. doi: 10.1016/j.jneuroim.2009.10.002. Epub 2009 Oct 21.
2009
AOU San Luigi di Orbassano

Marnetto F; Hellias B; Granieri L; Frau J; Patanella AK; Nytrova P; Sala A; Capobianco M; Gilli F; Bertolotto A;

Interferon-beta responders and non-responders. A biological approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S216-7. doi: 10.1007/s10072-008-0941-2.
2008
AOU San Luigi di Orbassano

Bertolotto A; Gilli F;

Predictive markers for response to interferon therapy in patients with multiple sclerosis. in Neurology / Neurology. 2008 Mar 25;70(13 Pt 2):1119-27. doi: 10.1212/01.wnl.0000304040.29080.7b. Epub 2008 Feb 1
2008
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A;

Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera. in Journal of immunological methods / J Immunol Methods. 2008 Jul 31;336(2):119-26. doi: 10.1016/j.jim.2008.04.002. Epub 2008 Apr 28.
2008
AOU San Luigi di Orbassano

Gilli F; van Beers M; Marnetto F; Jiskoot W; Bertolotto A; Schellekens H;

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis. in Neurology / Neurology. 2008 Dec 9;71(24):1940-7. doi: 10.1212/01.wnl.0000327340.50284.8d. Epub 2008 Oct 29.
2008
AOU San Luigi di Orbassano

Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A;

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.
2007
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2007 Aug;28(4):209-11. doi: 10.1007/s10072-007-0823-z. Epub 2007 Aug 10.
2007
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A;

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. in Journal of immunological methods / J Immunol Methods. 2007 Apr 10;321(1-2):19-31. doi: 10.1016/j.jim.2006.12.012. Epub 2007 Feb 20.
2007
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F;

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.
2006
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;

Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Dec;12(6):738-46. doi: 10.1177/1352458506070968.
2006
AOU San Luigi di Orbassano

Gilli F; Hoffmann F; Sala A; Marnetto F; Caldano M; Valentino P; Kappos L; Bertolotto A; Lindberg RL;

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.
2005
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2005 Dec;26 Suppl 4:S213-4. doi: 10.1007/s10072-005-0517-3.
2005
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Gilli F; Marnetto F; Caldano M; Sala A; Bertolotto A;

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.
2004
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. in Neurology / Neurology. 2004 Jun 8;62(11):2031-7. doi: 10.1212/01.wnl.0000129265.73259.9e.
2004
AOU San Luigi di Orbassano

Malucchi S; Sala A; Gilli F; Bottero R; Di Sapio A; Capobianco M; Bertolotto A;

Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology / Mol Diagn. 2004;8(3):185-94. doi: 10.1007/BF03260063.
2004
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Stefanuto G; Rinaldi V; Farinazzo F; Malucchi S; Capobianco M; Caldano M; Sala A; Bertolotto A;

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y.
2003
AOU San Luigi di Orbassano

Milano E; Di Sapio A; Malucchi S; Capobianco M; Bottero R; Sala A; Gilli F; Bertolotto A;

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. in Neurology / Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5.
2003
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Capobianco M; Malucchi S; Milano E; Melis F; Marnetto F; Lindberg RL; Bottero R; Di Sapio A; Giordana MT;

Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients. in Journal of immunological methods / J Immunol Methods. 2002 Apr 1;262(1-2):187-90. doi: 10.1016/s0022-1759(02)00008-x.
2002
AOU San Luigi di Orbassano

Gilli F; Sala A; Bancone C; Salacone P; Gallo M; Gaia E; Bertolotto A;

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification. in Journal of immunological methods / J Immunol Methods. 2001 Oct 1;256(1-2):141-52. doi: 10.1016/s0022-1759(01)00434-3.
2001
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Audano L; Castello A; Magliola U; Melis F; Giordana MT;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte